Nanoscale imaging of an in vivo antigen-specific T cell immune response has not been reported. Here, the combined NSOM-and fluorescent QD-based nanotechnology was employed to perform immune-fluorescence imaging of antigen-specific TCR response in an in vivo model of clonal T cell expansion. The NSOM/QD system provided a bestoptical-resolution nanoscale imaging of Vγ2Vδ2 TCR on the membrane of nonstimulated Vγ2Vδ2 T cells. Prior to Ag-induced clonal expansion, these non-stimulating Vγ2Vδ2 TCR appeared to be distributed differently from their αβ TCR counterparts on cell-surface. Surprisingly, Vγ2Vδ2 TCR nanoclusters not only were formed but also sustained on the membrane during an in vivo clonal expansion of Vγ2Vδ2 T cells after phosphoantigen treatment. The TCR nanoclusters could array to form nanodomains or microdomains on the membrane of clonally-expanded Vγ2Vδ2 T cells. Interestingly, expanded Vγ2Vδ2 T cells bearing TCR nanoclusters or nanodomains were able to rerecognize phosphoantigen and to exert better effector function. These studies provided nanoscale insight into the in vivo T cell immune response.
INTRODUCTION
T cell receptors (TCR) play a crucial role in recognition of antigens and development of immune responses. While immune events for TCR-mediated recognition, signaling and activation are well described [1] [2] [3] [4] , nanoscale imaging of immunobiology of antigen-specific TCR during the in vivo clonal T cell expansion has not been studied. Since TCR trigger downstream signaling and activation after antigen recognition, some unique TCR nanostructures may develop after TCR contact on Ag/APC, and thus contribute to selected functions such as clonal expansion, effector function, contracting (clonal exhaustion), or differentiation. While this presumption can be tested by imaging or visualization of antigen-specific TCR during the in vivo T cell response, conventional imaging techniques using fluorescent or confocal microscopy do not have nanoscale opticalresolution power to reveal individual TCR and their dynamics during clonal expansion/maturation [1] [2] [3] [4] . Nanotechology-based imaging may make it possible to reveal TCR nanostructures in the context of T cell recognition of antigens and therefore provide new insight into T cell response or ultimately immunity 5 .
Nanotechnology is emerging as a multidisciplinary tool to advance life science and medicine 6, 7 . However, nanoscale imaging or dissecting of functional bio-molecules in cells remain challenging. Near-field scanning optical microscopy (NSOM) has proved to be a useful nanotechnology tool for studying hard and flat materials, but its application in biomedical research is still limited [8] [9] [10] [11] . Complicated natures of cell membranes or biological molecules make it difficult for NSOM to generate high spatial-resolution images. While home-made NSOM operating in liquid can yield images of biomolecules, the current commercial NSOM instruments are all designed for in-air imaging [12] [13] [14] [15] , posing a challenge for nanoscale imaging of cell-membrane proteins. Although NSOM combined with some common fluorescent materials were used for imaging 16 , the absence of highly photostable fluorophores for use in NSOM is perhaps one of the major reasons why NSOM has not been reproducibly used for nanoscale imaging of functional cellular molecules.
We made use of our expertise of γδ/αβ T cell biology 17 and nanotechnology 18, 19 to perform nanoscale immune-fluorescence imaging of antigen-specific T cell antigen receptor (TCR) response during the in vivo clonal activation/expansion. We first established a NSOM-and fluorescent quantum dot (QD)-based imaging system to generate a best-optical-resolution immune-fluorescence imaging of a cell-membraneprotein. We then used this powerful NSOM/QD imaging system to visualize nonengaging TCR molecules on the cell membrane of unstimulated Vγ2Vδ2 T cells and compared γδ TCR with their αβ TCR counterparts for membrane-distribution patterns prior to activation/expansion. Based on these studies, we determined whether some unique nanostructures of TCR molecules developed during the in vivo clonal T cell expansion. Such nanoscale imaging studies demonstrated that the high-density TCR nanoclusters not only were formed but also sustained on the membrane of clonally expanded Vγ2Vδ2 T cells, and that these TCR nanoclusters were associated with the capability of clonally expanded Vγ2Vδ2 T cells to re-recognize antigen and to exert effector function during the Ag-mediated clonal expansion.
MATERIALS AND METHODS

Animals. Eight cynomolgus (Macaca fascicularis) macaques, 4-8 years old, (3-5 kg
weight) were used for collection and purification of T cells from blood and assessed for in vivo Vγ2Vδ2 T-cell expansion by phosphoantigen HMBPP/IL-2 or Picostim/IL-2 treatment. Animals treated with Picostim/IL-2 were simultaneously vaccinated with intradermally with 10 6 CFU of BCG, which had no impact on early response because of intradermal route. The animal studies were approved by UIC IACUC.
Phosphoantigen compounds: HMBPP and Picostim. The phosphoantigen compound, (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) was analytic-pure synthetic compound with chemical structure identical to natural phosphoantigen produced from E.coli or mycobacteria 20 . PBL isolated freshly from the blood prospectively collected from each monkey were fixed briefly for 30 min by 2% formaldehyde in PBS buffer (pH 7.4) followed by x3 wash with PBS prior to the staining by primary antibody: anti-Vδ2 Ab, anti-Vγ2 Ab, anti-Vβ5
Ab, anti-Vβ3.1 Ab, anti-Vβ17 Ab, or other Abs. The short-term fixing protocol allowed us to readily stain all these T cell subpopulations without causing any activation effects (data not shown). After washing with PBS buffer, QD655-conjugated goat-anti-mouse IgG was added (or biotinylated goat anti-mouse IgG and then streptavidin-conjugated QD655) followed by x 2 wash with PBS. Both primary and secondary antibody reactions were done at 4 0 C for 30 min, and washed x 2 with PBS following the standard protocol.
To enrich the Ab-stained cells, cells were magnetically labeled with goat anti-mouse IgG MicroBeads (Miltenyi Biotec.). Then the cell suspension was loaded onto a MS column which was placed in the magnetic field of a Mini MACS Separator. After removal of the column from the magnetic field, the magnetically retained cells were eluted as the positively selected cells. The eluted cells were then ready for confocal and NSOM imaging. This enrichment procedure gave rise to up to 50-70% of Vδ2+, Vγ2+, Vβ3+, Vβ17+ or Vβ5+ T cells. Such a moderate level of enrichment using a less stringent washing of the column appeared to be adequate for evaluating antibody-staining specificity, since NSOM can detect both the specific Ab-stained cells and those control cells (as controls) that were negatively stained but still eluted from the magnetic column). After HMBPP/IL-2 or Picostim/IL-2 treatment, there was no need to enrich Vδ2+ or Vγ2+ T cells because the number of Vγ2Vδ2 T cells increased to >30-65% in the blood within days 4-7 after the treatment (Fig.4a, and Fig.5a ). should be necessary) were enough for subsequent NSOM imaging. Before NSOM imaging, fresh cover slips were cleaned and treated with 0.1% poly-L-lysine (Sigma) for more than 1 hour following by washing with double distilled water. A drop of mAbstained cell suspension in double distilled water was deposited onto the poly-L-lysine-coated cover slip, dried in air at 22 0 C for 1 hour as described (11) , and then subjected to NSOM imaging in transmission mode. In the quality-control experiments, the NSOM images of immune-stained cells dried for 1 hour were compared with the images of the same cells that were dried for 1 day or 7 days. We found that the fluorescent images of QD655-bound γδ TCR in those settings were highly comparable. In Aurora 3 NSOM operation (Veeco), the continuous wave semiconductor laser (Coherent, USA; Cube, 
Intracellular IFNγ or perforin staining
This was done as previously described 22 . PBL were stimulated using the HMBPP (10 ng/ml), stained intracellularly for IFNγ and The predominance of ~50 nm fluorescence dots corresponded to the dominant intensity distribution of individual fluorescent QD655 dots on the same glass substrate (Fig. 1e) .
QDs with 20 fluorescence counts were dominant and smallest ones among all the QDs on the glass substrate, which was consistent with the 40-50 nm FWHM dominance (Fig.1e) . Thus, these results demonstrated that the majority of QD655 molecules with 20 fluorescence counts were those fluorescence dots with a size of ~50 nm.
We also found that QD were more reproducible for NSOM imaging than other traditional fluorochromes. Ab-or streptavidin-conjugated QD, but not FITC, PE, APC, Pacific blue or Cy5, were photostable or resistant to photobleaching upon laser excitation (data not shown). Actually, Ab-conjugated QD655 bond to cell-membrane could maintain strong fluorescence after exposure in air for more than a week and repeatedly be imaged by NSOM. These findings indicated that the nanoscale, photostable, and long-lasting features of Ab-or streptavidin-conjugated QD were well suited for an NSOM-based imaging.
We then performed the NSOM-and QD-based imaging of non-engaging γδ TCR on the membrane of non-stimulated Vγ2Vδ2 T cells from monkeys. Phosphoantigenspecific Vγ2Vδ2 T cells constitute 60-95% of human circulating γδ T cells, and our earlier work has demonstrated that macaque Vγ2Vδ2 T cells can mount major clonal expansion and anti-mycobacterial responses 17 . The other reason for using this model is that Vγ2Vδ2 TCR recognize phosphoantigens including HMBPP 33, 34 , and anti-Vγ2 mAb can block HMBPP-mediated activation/expansion (data not shown). The NSOM/QD system conferred a nanoscale immune-fluorescence imaging of many individual non-engaging γδ TCR dots on cell membrane (Fig. 2) . The ~50 nm QD655-Ab-bound TCR dots were separated from each other and dominated on the membrane of non-stimulated Vγ2Vδ2
T cells (Fig.2c-2f) . Similar to what was seen for QDs on the glass substrate (Fig.1e) , QD-655-bound TCR dots that exhibited 20 fluorescence counts were dominant and weakest in intensisty among all the QD-bound TCR dots on the cell surface (Fig.2g) .
The dominance of QDs with 20 fluorescence counts corresponded to the dominance of ~50 nm FWHM TCR when the intensity distribution of the individual TCR dots was analyzed in comparisons with their size distribution (Fig. 2g ). An apparent relationship for FWHM data and intensity distribution between the QD655-Ab on glass substrate and QD655-Ab-bound TCR on cell-membrane under the same excitation condition suggested that ~50 nm immune-fluorescence TCR dots on the membrane likely represented basic TCR complex that are detectable using NSOM/QD nanotechnology.
It is worth to mention that some fluorescent spots were < 50 nm, instead of 50 nm on cell-membrane. This might result from blinking property of fluorescent QD or NSOM convolution effects of contours and fluorescence of various degrees due to the height of QD655 (see Methods). However, the data of fluorescent size and intensity distribution suggested that they were parts of the immune fluorescence images of Vγ2Vδ2 TCR ( Fig.1e and Fig.2g ). On the other hand, there were detectable fluorescent TCR clusters that were approximately 2-, 3-, 4-or 5-fold bigger than 40-60 nm TCR dots (Fig.2g,   Fig.3c ). These fold-increasing immune-fluorescence TCR clusters may correspond to TCR complexes comprising of multiple TCR molecules of various amounts (Fig.3c ).
Prior to Ag-induced clonal expansion, non-engaging Vγ2Vδ2 TCR appeared to be distributed differently from non-engaging αβ TCR on cell membrane. Since Vγ2Vδ2 T cells are able to mount longer clonal expansion than CD4 or CD8 T cells in early infection 17 , we employed the NSOM/QD system to examine any difference in distribution patterns of cell-membrane TCR between Vγ2Vδ2 T cells and their αβ T cell counterparts prior to Ag-induced clonal expansion. Interestingly, a difference in distribution patterns of TCR on the cell surface was seen between Vγ2Vδ2 T cells and various Vβ-expressing αβ T cells (Fig.3, Fig. S1, Fig.5b) . A glimpse of images indicated that large TCR dots were dominant on αβ T cells (Figs.2-3, Fig. S1 , Fig.5b ), whereas ~50 nm γδ TCR were predominant on γδ T cells (Fig. 2-3 , Fig.5b and Fig. S1 ).
Computer-based analyses showed that 40-60 nm (~80%) and 60-90 nm (~10%) small γδ TCR dots were predominantly distributed on cell surface, whereas αβ T cells expressed more pre-existing large TCR dots (~40%) that were > 90 nm FWHM than γδ T cells (Fig.3) . Such a difference was statistically significant (p<0.05). The HMBPP + IL-2 treatment reproducibly induced remarkable expansion of macaque Vγ2Vδ2 T cells in the blood circulation (Fig.4a ) ; Picostim (almost identical to HMBPP) + IL-2 treatment similarly resulted in major expansion of Vγ2Vδ2 T cells as well (Fig.4b) . The confocal microscopy showed that while all the Vγ2Vδ2 T cells examined on days 4 and 7 after the HMBPP/IL-2 or Picostim/IL-2 treatment exhibited increased density of Vγ2Vδ2 TCR in the plasma membrane, the high-density TCR were displayed as aggregates or capped dots due to the limited resolution of confocal microscopy ( Fig.4c-4d , Fig.S2 and S3 in the supplementary).
TCR nanoclusters
Since confocal microscopy was not able to reveal a high-resolution image of the activation-related TCR aggregates, we utilized the NSOM/QD imaging system to dissect (Fig. 5a and 5c ). This was contrasted to the dominance of ~50 nm TCR dots on the membrane of non-stimulated Vγ2Vδ2 T cells (Fig.2, 3 , 5b). The computer-based quantitative analyses of fluorescent dots indicated that while TCR nanoclusters (≤ 250 nm) and nanodomains (> 250 nm)
were readily seen, 270-390 nm TCR nanodomains were most frequent among the detectable TCR clusters on the membrane of the clonally expanded Vγ2Vδ2 T cells after the HMBPP/IL-2 treatment (Fig. 5a-5c ). The TCR nanoclusters were also congregated to form many larger nanodomains ranging from 450 nm to 810 nm and a few microdomains with sizes > 1,000 nm ( Fig.5a and 5c) . Similarly, high-density TCR nanoclusters, nanodomains, and microdomains were also seen on the membrane of clonally-expanded Vγ2Vδ2 T cells on days 4 and 7 after the phosphoantigen Picostim/IL-2 treatment (Fig. 6) . The high-density TCR nanoclusters/nanodomains revealed by the NSOM/QD system of clonally expanded Vγ2Vδ2 T cells appeared to be the detailed nanographs dissecting those undistinguished TCR aggregates or cappings as seen vaguely under confocal microscopy ( Fig.4b, Fig.S2 and S3) . Therefore, these findings demonstrated that high-density TCR nanoclusters not only were formed but also sustained on the membrane of clonally expanded Vγ2Vδ2 T cells after the phosphoantigen/IL-2 treatment. were re-stimulated with phosphoantigen HMBPP, and assessed for the ability to rerecognize the antigen and mediate effector function. Surprisingly, a majority of Vγ2Vδ2
Clonally expanded Vγ2Vδ2 T cells bearing high-density TCR nanoclusters
T cells bearing high-density TCR nanoclusters were able to re-recognize the phosphoantigen HMBPP and produce cytokines (Fig.7) . While on day 4 after the HMBPP/IL-2 treatment, all clonally-expanded Vγ2Vδ2 T cells formed TCR nanoclusters and nanodomains with very few ~50 nm TCR dots detectable on cell surface (Fig.6,   Fig.5a, 5b, Fig.S2, S3 ), these cells were able to produce higher levels of anti-microbial cytokine IFN-γ or cytotoxic granule perforin when compared to base-line Vγ2Vδ2 T cells that displayed few or no nanoclusters (Fig.6a) . Similarly, on day 7 after the Picostim/IL-2 treatment, clonally-expanded Vγ2Vδ2 T cells bearing highly-engaged TCR nanoclusters were able to produce higher levels of IFN-γ or perforin after in vitro stimulation with HMBPP ( Fig.6, Fig.5a , 5b, Fig.S2, S3 ).
DISCUSSION
To our knowledge, the NSOM-and QD-based imaging system generated the best- 10 ms.
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